Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Farinati

Showing results (101-110 of 253) with videos related to

Pageof 26
Sort By:
Hepatology International|July 24, 2015
Circulating free DNA in the progression of liver damage to hepatocellular carcinomaMarika Piciocchi, Romilda Cardin, Alessandro Vitale, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2025
The current success of precision oncology relies on precision diagnostics: how quality and quantity of endoscopic biopsies impact cancer patient outcomeMatteo Fassan, Federica Grillo, Paola Parente, et al.
The American Journal of Gastroenterology|October 19, 2018
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 PatientsMassimo Rugge, Robert M Genta, Matteo Fassan, et al.
Journal of Hepatology|April 1, 2022
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and deathAlberto Zanetto, Elena Campello, Cristiana Bulato, et al.
Clinical and Experimental Medicine|March 26, 2021
Circulating prostaglandin E<sub>2</sub>: a novel potential prognostic biomarker in patients with hepatocellular carcinomaFilippo Pelizzaro, Maria Piera Kitenge, Romilda Cardin, et al.
Updates in Surgery|June 14, 2021
A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancerAlice Sabrina Tonello, Giulia Capelli, Quoc Riccardo Bao, et al.
The American Journal of Gastroenterology|January 8, 2008
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasivenessAdriana Sergio, Chiara Cristofori, Romilda Cardin, et al.
Biomarkers in Medicine|August 19, 2020
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differencesFilippo Pelizzaro, Federica Soldà, Romilda Cardin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 2, 2023
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolizationElisa Pinto, Filippo Pelizzaro, Romilda Cardin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 27, 2015
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesisMarika Piciocchi, Romilda Cardin, Umberto Cillo, et al.
Pageof 26

Showing results (101-110 of 253) with videos related to

Sort By:
Pageof 26
Hepatology International|July 24, 2015
Circulating free DNA in the progression of liver damage to hepatocellular carcinomaMarika Piciocchi, Romilda Cardin, Alessandro Vitale, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2025
The current success of precision oncology relies on precision diagnostics: how quality and quantity of endoscopic biopsies impact cancer patient outcomeMatteo Fassan, Federica Grillo, Paola Parente, et al.
The American Journal of Gastroenterology|October 19, 2018
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 PatientsMassimo Rugge, Robert M Genta, Matteo Fassan, et al.
Journal of Hepatology|April 1, 2022
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and deathAlberto Zanetto, Elena Campello, Cristiana Bulato, et al.
Clinical and Experimental Medicine|March 26, 2021
Circulating prostaglandin E<sub>2</sub>: a novel potential prognostic biomarker in patients with hepatocellular carcinomaFilippo Pelizzaro, Maria Piera Kitenge, Romilda Cardin, et al.
Updates in Surgery|June 14, 2021
A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancerAlice Sabrina Tonello, Giulia Capelli, Quoc Riccardo Bao, et al.
The American Journal of Gastroenterology|January 8, 2008
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasivenessAdriana Sergio, Chiara Cristofori, Romilda Cardin, et al.
Biomarkers in Medicine|August 19, 2020
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differencesFilippo Pelizzaro, Federica Soldà, Romilda Cardin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 2, 2023
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolizationElisa Pinto, Filippo Pelizzaro, Romilda Cardin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 27, 2015
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesisMarika Piciocchi, Romilda Cardin, Umberto Cillo, et al.
Pageof 26